Observations that Eg5 and CENPE inhibitors have been well-tolerated in patients suggest that inhibiting these kinesins in normal cells is relatively innocuous [75,125]; although, on-treatment tumour biopsies would be required to confirm effective suppression of target activity. The gene discussed is KIF11; the disease is neoplasm.